Saudi biotech startup Novo Genomics signed two major agreements: one with Tracer Biotechnologies to localize ctDNA monitoring ...

DUBLIN and BERWYN, Pa., June 17, 2025 (GLOBE NEWSWIRE) -- We are proud to announce that AscellaHealth has been awarded Gold ...

- 94% OS and 72% PFS observed at 6 months for atebimetinib (IMM-1-104) in combination with modified ...

The REGENT-1 study assessed the safety and feasibility of the Endogenex Pulsed Electric Field System (the ReCET System) – an investigational, endoscopic outpatient procedure that uses non-thermal ...

The company will present findings on two novel nanomedicine radiotracers: flurimedrimer, which selectively targets activated microglia in the human brain to support its neurology pipeline, and a ...

As we continue to execute, we remain focused on expanding insurance coverage for IB-Stim, which will make this much-needed therapy for abdominal pain associated with IBS and Pediatric Functional ...

Agitation/Aggression in PMS and other ASD-related patient subpopulations are the main focus of Oryzon’s VANDAM project included in the Med4Cure IPCEI project ...

SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX) (the “Company”), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and ...

Separately, Aptose announced that effective June 16, 2025, Ms. Carol Ashe has resigned as a director of the Company. The Company wishes to thank Ms. Ashe for her valuable contributions during her ...

Arndt Schottelius, MD PhD, CEO, commented: “We are delighted to welcome Stefan to Maxion at this pivotal time in our company's development. His exceptional track record in advancing novel therapeutics ...

Itasca (IL), United States - June 17, 2025. Biocartis Group of Companies (“Biocartis”), an innovative precision oncology company, is pleased to announce the appointment of Ben Svarczkopf, MS, MT (ASCP ...

Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and ...